Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from SYK

7 Stocks Worth Buying the Dip in Now... Or At Least Adding to Your Watchlist

While the S&P 500 notched another record close on Tuesday, 17 NYSE and Nasdaq Composite stocks fell to new 52-week lows. Here’s why the seven highest-priced names deserve a spot on your watchlist.

Stryker's Q1 2026 Earnings: What to Expect

Stryker's Q1 2026 Earnings: What to Expect

Stryker is ready to release its fiscal first-quarter earnings this month, and analysts project a single-digit profit growth.

How Is Stryker's Stock Performance Compared to Other Healthcare Stocks?

How Is Stryker's Stock Performance Compared to Other Healthcare Stocks?

Despite Stryker’s underperformance relative to its peers over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Stryker Earnings Preview: What to Expect

Stryker is set to report its fourth-quarter earnings next month, with Wall Street expecting high single-digit growth in the bottom line.

3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most

Healthcare behemoths, including the biggest name of them all, are increasing their dividends. Additionally, AMGN's dividend yield now sits solidly above 3%.

Stryker Stock: Is SYK Underperforming the Healthcare Sector?

Healthcare giant Stryker has notably underperformed the broader market over the past year, yet analysts remain optimistic about the stock’s prospects.

What Are Wall Street Analysts' Target Price for Stryker Stock?

Despite Stryker’s underperformance relative to the broader market over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

inkl

Read news from The Economist, FT, and more,
with one subscription

Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday?

Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday?

Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome Powell the day before.

Beware the Death Cross: 3 Stocks Triggering This Spooky Signal

Beware the Death Cross: 3 Stocks Triggering This Spooky Signal

The Death Cross is something you never want to see on a stock you own. Take caution with these three companies that recently were visited by this scary signal.

What You Need to Know Ahead of Stryker's Earnings Release

What You Need to Know Ahead of Stryker's Earnings Release

Stryker will release its third-quarter earnings later this month, and analysts anticipate a high single-digit bottom-line growth.

Is Stryker Stock Underperforming the Dow?

Is Stryker Stock Underperforming the Dow?

Stryker has underperformed the Dow over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Stryker Stock: Is Wall Street Bullish or Bearish?

Stryker Stock: Is Wall Street Bullish or Bearish?

Though Stryker has underperformed the SPX over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Is Stryker Stock Underperforming the Nasdaq?

Is Stryker Stock Underperforming the Nasdaq?

Although Stryker has slightly underperformed the Nasdaq over the past year, its fundamentals have remained strong, and analysts remain strongly bullish on the stock’s prospects.

Here's What to Expect From Stryker Corporation's Next Earnings Report

Here's What to Expect From Stryker Corporation's Next Earnings Report

Stryker Corporation is all geared to report its first-quarter results later this month, and analysts project its earnings to increase by a single digit.

Get all your
news in one place.

100's of premium titles.
One news app.

If You Could Only Hold 3 Investments for Life, Consider These

Discover 3 must-own investments for lifelong growth. From dividend stocks to a market-beating ETF, these picks offer stability, returns, and long-term wealth.

Is Stryker Stock Outperforming the S&P 500?

Stryker has outperformed the S&P 500 recently, and analysts remain highly optimistic about the stock’s prospects.

3 Robotics Stocks Powering the Future of Automation

Powered by rapid AI advancements, enhanced automation processes, and growing demand for commercial adoption, modern robotics is reshaping the automation landscape. Investors looking to capitalize on this momentum might find opportunities in Stryker (SYK), Fanuc Corporation (FANUY), and UiPath (PATH). Continue to read….

Do Wall Street Analysts Like Stryker Stock?

Although Stryker has lagged behind the S&P 500 Index over the past year, Wall Street analysts remain strongly optimistic about the stock's prospects.

Get all your
news in one place.

100's of premium titles.
One news app.

Stocks Steady Before the Open After Tech-Fueled Selloff, FOMC Meeting on Tap

March S&P 500 E-Mini futures (ESH25) are up +0.09%, and March Nasdaq 100 E-Mini futures (NQH25) are up +0.16% this morning, stabilizing after yesterday’s dramatic selloff, while investors awaited the start of the Federal Reserve’s two-day policy meeting as well as a flurry of U.S. economic data and corporate earnings…

Earnings Preview: What to Expect from Stryker’s Report

With Stryker gearing up to release its fourth-quarter earnings later this month, analysts expect a significant double-digit growth in earnings.

3 Stocks Helping to Bring AI to Healthcare

Many profitable companies are using AI to make healthcare more efficient; and these companies are rewarding investors with share price growth and dividends

3 MedTech Stocks to Grab Now for a Strong 2025

This article highlights three MedTech stocks poised for growth in 2025

How Is Stryker's Stock Performance Compared to Other Medical Device Stocks?

Stryker has substantially outpaced other medical device stocks over the past year and analysts remain strongly bullish on the stock’s prospects.

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos

Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.

Stryker Stock Outlook: Is Wall Street Bullish or Bearish?

Medtech giant Stryker has outperformed the broader market over the past year, and analysts remain moderately bullish on the stock’s prospects.

1 2 3

People

188,769 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

the Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Corporate Earnings

Places

372,728 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play